Mots-clés
 > MYOBASE > SOCIETE > démographie > épidémiologie > étude cas-témoins
étude cas-témoins
Commentaire :
Étude à visée étiologique qui implique d'emblée la comparaison de deux groupes : l'un composé de personnes atteintes de la maladie étudiée, appelées les « cas », et l'autre, de personnes n'ayant pas la maladie, appelées les « témoins ». La maladie sert en quelque sorte de point de départ ; on recherche ensuite un ou des facteurs d'exposition antérieurs susceptibles de l'expliquer. [source : Glossaire d'épidémiologie, LERTIM, Univ. de la Méditerranée - http://cybertim.timone.univ-mrs.fr/Members/rgiorgi/DossierPublic/Enseignement/Glossaire-RG#e]
|
Documents disponibles dans cette catégorie (115)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis
Tan SV, Suetterlin K, Männikkö R, et al.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2020, 131, 4, p 816
Preserved single muscle fiber specific force in facioscapulohumeral muscular dystrophy
Lassche S, Voermans NC, van der Pijl R, et al.
Neurology, 2020, 94, 11, p e1157
Electrical impedance myography as a biomarker of inclusion body myositis: A cross-sectional study
Roy B, Rutkove SB, Nowak RJ
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2020, 131, 2, p 368
Physical activity in myotonic dystrophy type 1
Knak KL, Sheikh AM, Witting N, et al.
Journal of neurology, 2020
Cognitive function and its relationship with brain structure in myotonic dystrophy type 1
Langbehn KE, van der Plas E, Moser DJ, et al.
Journal of neuroscience research, 2020
Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A
Wang H, Davison M, Wang K, et al.
Annals of clinical and translational neurology, 2020, 7, 1, p 69
Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy
Kessler T, Latzer P, Schmid D, et al.
Journal of neurochemistry, 2020
Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study
Bas J, Ogier AC, Le Troter A, et al.
Neurology, 2020
Evaluation of the cognitive-motor performance of adults with Duchenne Muscular Dystrophy in a hand-related task
Nizamis K, Schutte W, Grutters JJ, et al.
PLoS ONE, 2020, 15, 1
Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies
Vernerova L, Horvathova V, Kropackova T, et al.
Rheumatology (Oxford, England), 2020
The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis
Dos Santos AM, Misse RG, Borges IBP, et al.
Advances in rheumatology (London, England), 2019, 60, 1, p 3
Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2(*) Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla
Ates S, Deistung A, Schneider R, et al.
Frontiers in neurology, 2019, 10
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1
Cona G, Casagrande A, Lenzoni S, et al.
Journal of the International Neuropsychological Society : JINS, 2019
Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositis
Dieudonne Y, Allenbach Y, Benveniste O, et al.
Neurology, 2019
Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity
Dietz AR, Connolly A, Dori A, et al.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2019, 131, 1, p 1
Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy
Gunther R, Wurster CD, Cordts I, et al.
Frontiers in neurology, 2019, 10, 1098
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers
Viggiano E, Madej-Pilarczyk A, Carboni N, et al.
Genes, 2019, 10, 11
Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I
Alsaggaf R, Pfeiffer RM, Wang Y, et al.
International journal of cancer, 2019
Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study
Spaziani M, Semeraro A, Bucci E, et al.
Journal of endocrinological investigation, 2019
Characteristics of respiratory muscle involvement in myotonic dystrophy type 1
Henke C, Spiesshoefer J, Kabitz HJ, et al.
Neuromuscular disorders : NMD, 2019
Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis
Feng M, Guo H, Zhang C, et al.
International immunopharmacology, 2019, 77
Nasometric Scores in spinal and bulbar muscular atrophy - Effects of palatal lift prosthesis on dysarthria and dysphagia
Tanaka S, Hashizume A, Hijikata Y, et al.
Journal of the neurological sciences, 2019, 407
Chaperones in sporadic inclusion body myositis-Validation of proteomic data
Guttsches AK, Jacobsen F, Schreiner A, et al.
Muscle & Nerve, 2019
Glycogenin is dispensable for glycogen synthesis in human muscle and glycogenin deficiency causes polyglucosan storage
Visuttijai K, Carola HO, Thomsen C, et al.
The Journal of clinical endocrinology and metabolism, 2019
Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks
Naro A, Portaro S, Milardi D, et al.
Journal of neuroengineering and rehabilitation, 2019, 16, 1, p 116
